Spots Global Cancer Trial Database for adenocarcinoma of the stomach
Every month we try and update this database with for adenocarcinoma of the stomach cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Early Oral Feeding After Total Gastrectomy for Cancer | NCT01962519 | Adenocarcinoma ... | Early oral feed... | 18 Years - 80 Years | Jagiellonian University | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | NCT01406249 | Gastric Cancer | SP XP | 20 Years - 74 Years | Epidemiological and Clinical Research Information Network | |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
| S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | NCT00134095 | Gastric Cancer | irinotecan hydr... tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - 75 Years | National Cancer Institute (NCI) | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | NCT00335959 | Gastric Cancer | capecitabine oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | NCT00011960 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel adjuvant therap... radiation thera... | - | Radiation Therapy Oncology Group | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | NCT01472029 | Adenocarcinoma ... Adenocarcinoma ... | 5-FU, leucovori... Post-operative ... | 18 Years - | AIO-Studien-gGmbH | |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | NCT00978549 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain | docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
| DX-8951f in Treating Patients With Metastatic Stomach Cancer | NCT00017212 | Esophageal Canc... Gastric Cancer | exatecan mesyla... | 18 Years - | Daiichi Sankyo | |
| XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | NCT01412294 | Gastric Cancer | Capecitabine, C... | 20 Weeks - 74 Years | Epidemiological and Clinical Research Information Network | |
| BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | NCT00017056 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma | NCT03966118 | Gastroesophagea... Adenocarcinoma ... | Avelumab Ramucirumab Paclitaxel | 18 Years - | Charite University, Berlin, Germany | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | NCT05970627 | Adenocarcinoma ... Adenocarcinoma ... Epstein-Barr Vi... | Toripalimab Oxaliplatin S1 | 18 Years - 80 Years | First Affiliated Hospital of Zhejiang University | |
| Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach | NCT00004235 | Esophageal Canc... Gastric Cancer | docetaxel irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| XParTS II: Capecitabine/CDDP(XP) and S-1/CDDP(SP) as the First-line Treatment for Advanced Gastric Cancer | NCT01406249 | Gastric Cancer | SP XP | 20 Years - 74 Years | Epidemiological and Clinical Research Information Network | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | NCT00003862 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... paclitaxel conventional su... neoadjuvant the... radiation thera... | 0 Years - 120 Years | Radiation Therapy Oncology Group | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | NCT00002883 | Esophageal Canc... Gastric Cancer | cisplatin fluorouracil adjuvant therap... conventional su... neoadjuvant the... | 0 Years - 75 Years | UNICANCER | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | NCT00985192 | Esophageal Canc... Gastric Cancer | everolimus laboratory biom... | 18 Years - | Translational Oncology Research International | |
| Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | NCT00003192 | Esophageal Canc... Gastric Cancer | aminocamptothec... | 18 Years - | University of Chicago | |
| Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction | NCT01360086 | Adenocarcinoma ... Gastric Cancer | cetuximab cisplatin fluorouracil leucovorin calc... adjuvant therap... neoadjuvant the... quality-of-life... therapeutic con... | 18 Years - 75 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
| Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer | NCT00450203 | Oesophagogastri... | bevacizumab capecitabine cisplatin Epirubicin adjuvant therap... conventional su... neoadjuvant the... Lapatinib | 18 Years - | Medical Research Council | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG | NCT04878783 | Gastric Cancer Adenocarcinoma ... | CT scan | 18 Years - | University of Roma La Sapienza | |
| Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | NCT00004127 | Esophageal Canc... Gastric Cancer | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin | 18 Years - | University of Chicago | |
| Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer | NCT03647969 | Adenocarcinoma ... GastroEsophagea... | Nivolumab Ipilimumab mFOLFOX FLOT | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
| BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | NCT00017043 | Esophageal Canc... Gastric Cancer | ixabepilone | 18 Years - | Bristol-Myers Squibb | |
| Sorafenib. ICORG 06-41, V4 | NCT01158287 | Esophageal Canc... Gastric Cancer | sorafenib tosyl... laboratory biom... | 18 Years - | Cancer Trials Ireland | |
| Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | NCT00040859 | Esophageal Canc... Gastric Cancer | capecitabine oxaliplatin | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach | NCT01640782 | Adenocarcinoma ... Adenocarcinoma ... | Irinotecan, Leu... Leucovorin, 5-F... | 18 Years - 75 Years | Mario Negri Institute for Pharmacological Research | |
| Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | NCT00003298 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... paclitaxel surgery radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer | NCT00978549 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer Nausea and Vomi... Pain | docetaxel steroid therapy questionnaire a... nausea and vomi... pain therapy quality-of-life... standard follow... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma | NCT00871273 | Adenocarcinoma ... | capecitabine | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
| Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer | NCT01123473 | Adenocarcinoma ... Gastric Cancer | capecitabine cisplatin epirubicin hydr... fluorouracil lapatinib ditos... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] | NCT03329690 | Neoplasm, Gastr... | DS-8201a Physician's Cho... | 20 Years - | Daiichi Sankyo | |
| Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | NCT00005607 | Esophageal Canc... Gastric Cancer | FOLFIRI regimen fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | NCT01498289 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | FOLFOX regimen docetaxel fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer | NCT00982592 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri... | oxaliplatin leucovorin calc... fluorouracil placebo vismodegib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan in Treating Patients With Esophageal or Stomach Cancer | NCT00003748 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | NCT00017537 | Breast Cancer Gastric Cancer Lung Cancer Ovarian Cancer Unspecified Adu... | MVF-HER-2(628-6... | 18 Years - | University of Alabama at Birmingham | |
| Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction | NCT00054457 | Esophageal Canc... Gastric Cancer | capecitabine docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | NCT00526110 | Gastrointestina... | 5-Fluorouracil Docetaxel Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | NCT00963092 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | DNA analysis RNA analysis microarray anal... protein analysi... cytology specim... laboratory biom... questionnaire a... | 16 Years - | National Cancer Institute (NCI) | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | NCT00074009 | Gastric Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Assessing Quality of Life of Patients With Stomach Cancer | NCT00020826 | Gastric Cancer | quality-of-life... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach | NCT00020761 | Esophageal Canc... Gastric Cancer | irinotecan hydr... paclitaxel | 18 Years - | Jonsson Comprehensive Cancer Center | |
| FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer | NCT00098527 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Esoph... Recurrent Gastr... | romidepsin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | NCT00514020 | Gastric Cancer | fluorouracil leucovorin calc... oxaliplatin gene expression... polymorphism an... protein express... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer | NCT00607594 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Gastr... Stage III Gastr... Stage III Esoph... Stage IV Esopha... Stage IV Gastri... | saracatinib | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | NCT00052910 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil leucovorin calc... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
| Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | NCT01472029 | Adenocarcinoma ... Adenocarcinoma ... | 5-FU, leucovori... Post-operative ... | 18 Years - | AIO-Studien-gGmbH | |
| Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
| S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer | NCT00182611 | Gastric Cancer | cisplatin tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | NCT00009880 | Esophageal Canc... Gastric Cancer | filgrastim cisplatin fluorouracil paclitaxel radiation thera... | - | Radiation Therapy Oncology Group | |
| XParTS: Capecitabine/Cisplatin(XP) for Recurrent Gastric Cancer | NCT01412294 | Gastric Cancer | Capecitabine, C... | 20 Weeks - 74 Years | Epidemiological and Clinical Research Information Network | |
| DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] | NCT03329690 | Neoplasm, Gastr... | DS-8201a Physician's Cho... | 20 Years - | Daiichi Sankyo | |
| Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach | NCT00003237 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel surgical proced... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
